Environmental co-factors in HPV carcinogenesis

Virus Research

Volumn 89, Issue 2, 2002, Pages 191-199

  Castellsagué, Xavier ^a   Bosch, F Xavier ^a   Muñoz, Nubia ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Cervical cancer; Co factors; HPV; Oral contraceptives; Parity; Smoking

Indexed keywords

FOLIC ACID; ORAL CONTRACEPTIVE AGENT; VIRUS DNA; VIRUS PROTEIN;

CANCER CYTODIAGNOSIS; CANCER INVASION; CANCER RISK; CIRCUMCISION; CONFERENCE PAPER; DIETARY INTAKE; DISEASE COURSE; HEALTH SURVEY; HUMAN; LONG TERM CARE; MALIGNANT TRANSFORMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SEXUALLY TRANSMITTED DISEASE; SMOKING; SOCIOECONOMICS; SPECIES DIFFERENCE; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; VIRUS CARCINOGENESIS; VIRUS DETECTION; VIRUS INFECTION; VIRUS REACTIVATION; WART VIRUS;

CONTRACEPTIVES, ORAL; ENVIRONMENT; FEMALE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PARITY; RISK FACTORS; SMOKING; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

NICOTIANA TABACUM;

EID: 0036849784     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(02)00188-0     Document Type: Conference Paper

References (42)

1. Anttila T., Saikku P., Koskela P., Bloigu A., Dillner J., Ikaheimo I., et al. Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. J. Am. Med. Assoc. 285:(1):2001;47-51.
2. Arbeit J.M., Howley P.M., Hanahan D. Chronic estrogen-induced cervical and vaginal squamous carcinogenesis in human papillomavirus type 16 transgenic mice. Proc. Natl. Acad. Sci. USA. 93:(7):1996;2930-2935.
3. Autier P., Coibion M., Huet F., Grivegnee A.R. Transformation zone location and intraepithelial neoplasia of the cervix uteri. Br. J. Cancer. 74:(3):1996;488-490.
4. Beasley R.P., Trepo C., Stevens C.E., Szmuness W. The E antigen and vertical transmission of hepatitis B surface antigen. Am. J. Epidemiol. 105:(2):1977;94-98.
5. Bosch F.X., Lorincz A., Munoz N., Meijer C.J., Shah K.V. The causal relation between human papillomavirus and cervical cancer. J. Clin. Pathol. 55:(4):2002;244-265.
6. Castellsague X., Bosch F.X., Munoz N., Meijer C.J., Shah K.V., de Sanjose S., et al. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. New Engl. J. Med. 346:(15):2002;1105-1112.
7. Castle P.E., Hillier S.L., Rabe L.K., Hildesheim A., Herrero R., Bratti M.C., et al. An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV). Cancer Epidemiol. Biomark. Prev. 10:(10):2001;1021-1027.
8. Coursaget P., Yvonnet B., Chotard J., Vincelot P., Sarr M., Diouf C., et al. Age and sex-related study of hepatitis B virus chronic carrier state in infants from an endemic area (Senegal). J. Med. Virol. 22:(1):1987;1-5.
9. Deacon J.M., Evans C.D., Yule R., Desai M., Binns W., Taylor C., et al. Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort. Br. J. Cancer. 83:(11):2000;1565-1572.
10. de Sanjose S., Bosch F.X., Muñoz N., et al. Social differences in sexual behaviour and cervical cancer. Kogevinas M.P.N., Susser M., et al. Social Inequalities and Cancer. 1997;309-317 IARC Scientific Publications, Lyon.
11. Elson D.A., Riley R.R., Lacey A., Thordarson G., Talamantes F.J., Arbeit J.M. Sensitivity of the cervical transformation zone to estrogen-induced squamous carcinogenesis. Cancer Res. 60:(5):2000;1267-1275.
12. Evans A.S., Niederman J.C. Epstein-Barr virus. Evans A.S., Viral Infections of Humans. 1989;265-292 Plenum Press, New York.
13. Ferrera A., Velema J.P., Figueroa M., Bulnes R., Toro L.A., Claros J.M., et al. Co-factors related to the causal relationship between human papillomavirus and invasive cervical cancer in Honduras. Int. J. Epidemiol. 29:(5):2000;817-825.
14. Goodman M.T., McDuffie K., Hernandez B., Wilkens L.R., Bertram C.C., Killen J., et al. Association of methylenetetrahydrofolate reductase polymorphism C677T and dietary folate with the risk of cervical dysplasia. Cancer Epidemiol. Biomark. Prev. 10:2001;1275-1280.
15. Hildesheim A., Herrero R., Castle P.E., Wacholder S., Bratti M.C., Sherman M.E., et al. HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica. Br. J. Cancer. 84:(9):2001;1219-1226.
16. Ho G.Y., Kadish A.S., Burk R.D., Basu J., Palan P.R., Mikhail M., et al. HPV 16 and cigarette smoking as risk factors for high-grade cervical intra-epithelial neoplasia. Int. J. Cancer. 78:(3):1998;281-285.
17. IARC, 1986. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, vol. 38, Tobacco smoking, International Agency for Research on Cancer, Lyon.
18. IARC, 1995. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 64. Human Papillomaviruses, International Agency for Research on Cancer, Lyon, 1995.
19. IARC, 1999. IARC Monographs on the Evaluation of the Carcinogenic Risk to Humans, vol. 72, Hormonal contraception and post-menopausal hormonal therapy, International Agency for Research on Cancer, Lyon.
20. Kruger-Kjaer S., van den Brule A.J., Svare E.I., Engholm G., Sherman M.E., Poll P.A., et al. Different risk factor patterns for high-grade and low-grade intraepithelial lesions on the cervix among HPV-positive and HPV-negative young women. Int. J. Cancer. 76:(5):1998;613-619.
21. Lacey J.V. Jr, Brinton L.A., Abbas F.M., Barnes W.A., Gravitt P.E., Greenberg M.D., et al. Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas. Cancer Epidemiol. Biomark. Prev. 8:(12):1999;1079-1085.
22. La Ruche G., You B., Mensah-Ado I., Bergeron C., Montcho C., Ramon R., et al. Human papillomavirus and human immunodeficiency virus infections: relation with cervical dysplasia-neoplasia in African women. Int. J. Cancer. 76:(4):1998;480-486.
23. Mitrani-Rosenbaum S., Tsvieli R., Tur-Kaspa R. Oestrogen stimulates differential transcription of human papillomavirus type 16 in SiHa cervical carcinoma cells. J. Gen. Virol. 70:1989;2227-2232.
24. Moreno V., Munoz N., Bosch F.X., de Sanjose S., Gonzalez L.C., Tafur L., et al. Risk factors for progression of cervical intraepithelial neoplasm grade III to invasive cervical cancer. Cancer Epidemiol. Biomark. Prev. 4:(5):1995;459-467.
25. Moreno V., Bosch F.X., Munoz N., Meijer C.J., Shah K.V., Walboomers J.M., et al. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study. Lancet. 359:(9312):2002;1085-1092.
26. Munoz N., Franceschi S., Bosetti C., Moreno V., Herrero R., Smith J.S., et al. Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet. 359:(9312):2002;1093-1101.
27. Plummer, M., Herrero, R., Franceschi, S., Meijer, C.J.L.M., Snijders, P., Bosch, F.X., et al., 2002. Smoking and cervical cancer: Pooled analysis of a multicentric case-control study. Br. Med. J., submitted for publication.
28. Poppe W.A., Ide P.S., Drijkoningen M.P., Lauweryns J.M., Van Assche F.A. Tobacco smoking impairs the local immunosurveillance in the uterine cervix. An immunohistochemical study. Gynecol. Obstet. Invest. 39:(1):1995;34-38.
29. Prokopczyk B., Cox J.E., Hoffmann D., Waggoner S.E. Identification of tobacco-specific carcinogen in the cervical mucus of smokers and nonsmokers. J. Natl. Cancer Inst. 89:(12):1997;868-873.
30. Public Health Service 2, 2001. Surgeon General's Advisory Committee on Women and Smoking. Available online: http://www.cdc.gov/tobacco.
31. Rous P., Friedwald W. The effect of chemical carcinogens on virus-induced rabbit papillomas. J. Exp. Med. 79:1944;511-538.
32. Schiffman M.H., Bauer H.M., Hoover R.N., Glass A.G., Cadell D.M., Rush B.B., et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J. Natl. Cancer Inst. 85:(12):1993;958-964.
33. Sethi S., Muller M., Schneider A., Blettner M., Smith E., Turek L., et al. Serologic response to the E4, E6, and E7 proteins of human papillomavirus type 16 in pregnant women. Am. J. Obstet. Gynecol. 178:(2):1998;360-364.
34. Smith, J.S., Bosetti, C., Muñoz, N., Bosch, F.X., Eluf-Neto, J. et al. 2002a Herpes simplex virus-2 as an HPV cofactor in the etiology of invasive cervical cancer: A pooled analysis of the IARC multicentric case-control study. J. Natl. Cancer Inst., in press.
35. Smith J.S., Muñoz N., Herrero R., Eluf-Neto J., Ngelangel C., Franceschi S., et al. Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in brazil and the Philippines. J. Infect. Dis. 185:2002b;324-331.
36. Szarewski A., Cuzick J. Smoking and cervical neoplasia: a review of the evidence. J. Epidemiol. Biostat. 3:1998;229-256.
37. Szarewski A., Jarvis M.J., Sasieni P., Anderson M., Edwards R., Steele S.J., et al. Effect of smoking cessation on cervical lesion size. Lancet. 347:(9006):1996;941-943.
38. Thomas D.B., Qin Q., Kuypers J., Kiviat N., Ashley R.L., Koetsawang A., et al. Human papillomaviruses and cervical cancer in Bangkok II. Risk factors for in situ and invasive squamous cell cervical carcinomas. Am. J. Epidemiol. 153:(8):2001;732-739.
39. Walboomers J.M.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189:1999;12-19.
40. Winkelstein W. Jr. Smoking and cancer of the uterine cervix: Hypothesis. Am. J. Epidemiol. 106:(4):1977;257-259.
41. Working group on Diet and Cancer,1998. Working Group on Diet and Cancer of the Committee on Medical Aspects of Food and Nutrition Policy, Nutritional Aspects of the Development of Cancer, Department of Health, UK.
42. Yang X., Jin G., Nakao Y., Rahimtula M., Pater M.M., Pater A. Malignant transformation of HPV 16-immortalized human endocervical cells by cigarette smoke condensate and characterisation of multistage carcinogenesis. Int. J. Cancer. 65:(3):1996;338-344.